You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
| Title |
Reduction of exacerbations by the PDE4 inhibitor roflumilast - the importance of defining different subsets of patients with COPD
|
|---|---|
| Published in |
Respiratory Research, December 2011
|
| DOI | 10.1186/1465-9921-12-18 |
| Pubmed ID | |
| Authors |
Stephen I Rennard, Peter MA Calverley, Udo M Goehring, Dirk Bredenbröker, Fernando J Martinez |
| Abstract |
As chronic obstructive pulmonary disease (COPD) is a heterogeneous disease it is unlikely that all patients will benefit equally from a given therapy. Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, has been shown to improve lung function in moderate and severe COPD but its effect on exacerbations in unselected populations was inconclusive. This led to the question of whether a responsive subset existed that could be investigated further. |
Mendeley readers
The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| Germany | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 123 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 28 | 22% |
| Other | 20 | 16% |
| Student > Ph. D. Student | 11 | 9% |
| Student > Bachelor | 11 | 9% |
| Professor > Associate Professor | 10 | 8% |
| Other | 32 | 25% |
| Unknown | 15 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 59 | 46% |
| Agricultural and Biological Sciences | 14 | 11% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 6% |
| Biochemistry, Genetics and Molecular Biology | 7 | 6% |
| Economics, Econometrics and Finance | 5 | 4% |
| Other | 12 | 9% |
| Unknown | 22 | 17% |